Advanced search
Publication Cover
Journal of Biomolecular Structure and Dynamics Volume 37, 2019 - Issue 10
Journal homepage
506
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Exploring dengue proteome to design an effective epitope-based vaccine against dengue virus

Soudabeh SabetianPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;
,
Navid NezafatPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; ;Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran;
,
Hesam DorostiPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; ;Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran;
,
Mahboubeh ZareiPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; ;Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran;
&
Younes GhasemiPharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; ;Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; ;Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran; ;Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, IranCorrespondence[email protected]
Pages 2546-2563 | Received 02 Feb 2018, Accepted 01 Jun 2018, Published online: 17 Nov 2018

  • Andreatta, M., & Nielsen, M. (2016). Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics, 32, 511–517.
  • Amexis, G., & Young, N. S. (2007). Multiple antigenic peptides as vaccine platform for the induction of humoral responses against dengue-2 virus. Viral Immunology, 20, 657–663.
  • Amorim, J. H., Diniz, M. O., Cariri, F. A., Rodrigues, J. F., Bizerra, R. S. P., Gonçalves, A. J., & de Souza Ferreira, L. C. (2012). Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant. Vaccine, 30, 837–845.
  • Azmi, F., Ahmad Fuaad, A. A. H., Skwarczynski, M., & Toth, I. (2014). Recent progress in adjuvant discovery for peptide-based subunit vaccines. Human Vaccines & Immunotherapeutics, 10, 778–796.
  • Barone, D., Balasco, N., Autiero, I., & Vitagliano, L. (2017). The dynamic properties of the hepatitis C virus E2 envelope protein unraveled by molecular dynamics. Journal of Biomolecular Structure and Dynamics, 35, 805–816.
  • Baseer, S., Ahmad, S., Ranaghan, K. E., & Azam, S. S. (2017). Towards a peptide-based vaccine against Shigella sonnei: A subtractive reverse vaccinology based approach. Biologicals, 50, 87–99
  • Bernstein, F. C., Koetzle, T. F., Williams, G. J., Meyer, E. F., Brice, M. D., Rodgers, J. R., & Tasumi, M. (1977). The protein data bank. A computer-based archival file for macromolecular structures FEBS. European Journal of Biochemistry, 80, 319–324.
  • Bhardwaj, N., Gnjatic, S., & Sawhney, N. B. (2010). TLR Toll-like receptor agonists: Are they good adjuvants? Cancer journal (Sudbury, Mass.), 16, 382.
  • Bhasin, M., & Raghava, G. (2004). Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine, 22, 3195–3204.
  • Bienert, S., Waterhouse, A., de Beer, T. A., Tauriello, G., Studer, G., Bordoli, L., & Schwede, T. (2016). The SWISS-MODEL repository-new features and functionality. Nucleic Acids Res, 45, D313–D319.
  • Bui, H.-H., Sidney, J., Li, W., Fusseder, N., & Sette, A. (2007). Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC bioinformatics, 8(1), p. 361.
  • Calis, J. J., Maybeno, M., Greenbaum, J. A., Weiskopf, D., De Silva, A. D., Sette, A., & Peters, B. (2013). Properties of MHC class I presented peptides that enhance immunogenicity. PLOS Computational Biology, 9, e1003266.
  • Chen, H.-F., Yu, C.-Y., Chen, M.-J., Chou, S.-H., Chiang, M.-S., Chou, W.-H., … Ho, H.-N. (2015). Characteristic expression of major histocompatibility complex and immune privilege genes in human pluripotent stem cells and their derivatives. Cell Transplant, 24, 845–864.
  • Christian, E. A., Kahle, K. M., Mattia, K., Puffer, B. A., Pfaff, J. M., Miller, A., & Doranz, B. J. (2013). Atomic-level functional model of dengue virus Envelope protein infectivity. Proceedings of the National Academy of Science of the United States of America, 110, 18662–18667.
  • Colovos, C., & Yeates, T. O. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science, 2, 1511–1519. doi:10.1002/pro.5560020916
  • Connell, T. D. (2007). Cholera toxin, LT-I, LT-IIa, and LT-IIb: The critical role of ganglioside-binding in immunomodulation by type I and type II heat-labile enterotoxins. Expert Review of Vaccines, 6, 821–834. doi:10.1586/14760584.6.5.821. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2849181/
  • Cook, G. C., & Zumla, A. (2008). Manson's tropical diseases (22nd ed.). Philadelphia, US: Elsevier Health Sciences.
  • Depla, E., Van der Aa, A., Livingston, B. D., Crimi, C., Allosery, K., De Brabandere, V., … Power, S. (2008). Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections. Journal of Virology, 82(1), 435–450.
  • Diaz, A. A., Tomba, E., Lennarson, R., Richard, R., Bagajewicz, M. J., & Harrison, R. G. (2010). Prediction of protein solubility in Escherichia coli using logistic regression. Biotechnology and Bioengineering, 105, 374–383.
  • Dimitrov, I., Garnev, P., Flower, D. R., & Doytchinova, I. (2010). EpiTOP-a proteochemometric tool for MHC class II binding prediction. Bioinformatics, 26, 2066–2068.
  • Dimitrov, I., Naneva, L., Doytchinova, I., & Bangov, I. (2014). AllergenFP: Allergenicity prediction by descriptor fingerprints. Bioinformatics, 30, 846–851. Retrieved from http://dx.doi.org/10.1093/bioinformatics/btt619
  • dos Santos Alves, R. P., Pereira, L. R., Fabris, D. L. N., Salvador, F. S., Santos, R. A., de Andrade Zanotto, P. M., & de Souza Ferreira, L. C. (2016). Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen. Clinical and Vaccine Immunology, 23, 460–469.
  • Doytchinova, I. A., & Flower, D. R. (2007). Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties. Vaccine, 25, 856–866.
  • Duthie, M. S., Windish, H. P., Fox, C. B., & Reed, S. G. (2011). Use of defined TLR ligands as adjuvants within human vaccines. Immunological Reviews, 239(1), 178–196.
  • Eisenberg, D., Lüthy, R., & Bowie, J. U. (1997). VERIFY3D: Assessment of protein models with three-dimensional profiles. Methods in enzymology, 277, 396–404.
  • Fahimi, H., Sadeghizadeh, M., & Mohammadipour, M. (2016). In silico analysis of an envelope domain III-based multivalent fusion protein as a potential dengue vaccine candidate. Clinical and Experimental Vaccine Research, 5(1), 41–49. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742598/
  • Fajardo-Sánchez, E., Galiano, V., & Villalaín, J. (2017). Molecular dynamics study of the membrane interaction of a membranotropic dengue virus C protein-derived peptide. Journal of Biomolecular Structure and Dynamics, 35, 1283–1294.
  • Farhadi, T., & Ranjbar, M. M. (2017). Designing and modeling of complex DNA vaccine based on MOMP of Chlamydia trachomatis: An in silico approach. Network Modeling Analysis in Health Informatics and Bioinformatics, 6(1), 1.
  • Fleith, R. C., Lobo, F. P., dos Santos, P. F., Rocha, M. M., Bordignon, J., Strottmann, D. M., … Mansur, D. S. (2016). Genome-wide analyses reveal a highly conserved dengue virus envelope peptide which is critical for virus viability and antigenic in humans. Nature, 6, 36339. Retrieved from http://dx.doi.org/10.1038/srep36339
  • Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M.R., Appel, R.D., & Bairoch, A. (2005) Protein identification and analysis tools on the ExPASy server. In The Proteomics Protocols Handbook, edited by J. M. Walker. (pp. 571–607). Totowa, USA: Humana Press.
  • Ghosh, A., & Dar, L. (2015). Dengue vaccines: Challenges, development, current status and prospects. Indian Journal of Medical Microbiology, 33(1), 3.
  • Gupta, S., Kapoor, P., Chaudhary, K., Gautam, A., Kumar, R., Raghava, G. P., & Consortium, O. S. D. D. (2013). In silico approach for predicting toxicity of peptides and proteins. PLoS One, 8, e73957.
  • Gutjahr, A., Tiraby, G., Perouzel, E., Verrier, B., & Paul, S. (2016). Triggering intracellular receptors for vaccine adjuvantation. Trends in Immunology, 37, 573–587.
  • Guy, B., & Jackson, N. (2016). Dengue vaccine: Hypotheses to understand CYD-TDV-induced protection. Nature Reviews Microbiology, 14(1), 45.
  • Hajishengallis, G., & Connell, T. D. (2013). Type II heat-labile enterotoxins: Structure, function, and immunomodulatory properties. Veterinary Immunology and Immunopathology, 152(1), 68–77.
  • Hamza, A., Kebaier, C., Vasilescu, D., Sarma, M., & Sarma, R. (2003). Molecular modeling of a Leishmania antigen eIF-4A: Identification of a potential epitope implicated in the adjuvant effect. Journal of Biomolecular Structure and Dynamics, 21(1), 43–53.
  • Heo, L., Park, H., & Seok, C. (2013). GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Research, 41, W384–W388. doi:10.1093/nar/gkt458
  • Hertz, T., Beatty, P. R., MacMillen, Z., Killingbeck, S. S., Wang, C., & Harris, E. (2017). Antibody epitopes identified in critical regions of dengue virus nonstructural 1 protein in mouse vaccination and natural human infections. Journal of Immunology, 198, 4025–4035.
  • Hussain, M., Idrees, M., & Afzal, S. (2015). Development of global consensus of dengue virus envelope glycoprotein for epitopes based vaccine design. Current Computer-Aided Drug Design, 11(1), 84–97.
  • Ishikawa, T., Yamanaka, A., & Konishi, E. (2014). A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available. Vaccine, 32, 1326–1337. Retrieved from http://www.sciencedirect.com/science/article/pii/S0264410X14000747
  • Jiang, L., Zhou, J.-M., Yin, Y., Fang, D.-Y., Tang, Y.-X., & Jiang, L.-F. (2010). Selection and identification of B-cell epitope on NS1 protein of dengue virus type 2. Virus Research, 150, 49–55.
  • Jin, M. S., Kim, S. E., Heo, J. Y., Lee, M. E., Kim, H. M., Paik, S.-G., … Lee, J.-O. (2007). Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell, 130, 1071–1082.
  • Källberg, M., Wang, H., Wang, S., Peng, J., Wang, Z., Lu, H., & Xu, J. (2012). Template-based protein structure modeling using the RaptorX web server. Nature Protocols, 7, 1511–1522. Retrieved from http://dx.doi.org/10.1038/nprot.2012.085
  • Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N., & Sternberg, M. J. E. (2015). The Phyre2 web portal for protein modeling, prediction and analysis. Nature Protocols, 10, 845–858. Retrieved from http://dx.doi.org/10.1038/nprot.2015.053
  • Ko, J., Park, H., Heo, L., & Seok, C. (2012). GalaxyWEB server for protein structure prediction and refinement. Nucleic Acids Research, 40, W294–W297. doi:10.1093/nar/gks493
  • Kringelum, J. V., Lundegaard, C., Lund, O., & Nielsen, M. (2012). Reliable B cell epitope predictions: Impacts of method development and improved benchmarking. PLoS Computational Biology, 8, p e1002829.
  • Krogh, A., Larsson, B., von Heijne, G., & Sonnhammer, E. L. (2001). Predicting transmembrane protein topology with a hidden Markov model: Application to complete genomes. Journal of Molecular Biology, 305, 567–580. doi:10.1006/jmbi.2000.4315
  • Kuno, G. (2009). Emergence of the severe syndrome and mortality associated with dengue and dengue-like illness: Historical records (1890 to 1950) and their compatibility with current hypotheses on the shift of disease manifestation. Clinical Microbiology Reviews, 22, 186–201.
  • Lai, C.-Y., Tsai, W.-Y., Lin, S.-R., Kao, C.-L., Hu, H.-P., King, C.-C., … Wang, W.-K. (2008). Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. Journal of Virology, 82, 6631–6643. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2447043/
  • Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26, 283–291.
  • Li, X., Guo, L., Kong, M., Su, X., Yang, D., Zou, M., … Lu, L. (2015). Design and evaluation of a multi-epitope peptide of human metapneumovirus. Intervirology, 58, 403–412.
  • Liang, S., & Hajishengallis, G. (2010). Heat-labile enterotoxins as adjuvants or anti-inflammatory agents. Immunological Investigations, 39, 449–467. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819675/
  • Livingston, B., Crimi, C., Newman, M., Higashimoto, Y., Appella, E., Sidney, J., & Sette, A. (2002). A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes. Journal of Immunology, 168, 5499–5506.
  • Lundegaard, C., Lund, O., Buus, S., & Nielsen, M. (2010). Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology, 130, 309–318. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913210/
  • Ma, Y. (2016). Recent advances in nontoxic Escherichia coli heat-labile toxin and its derivative adjuvants. Expert Reviews of Vaccines, 15, 1361–1371.
  • Magnan, C. N., Zeller, M., Kayala, M. A., Vigil, A., Randall, A., Felgner, P. L., & Baldi, P. (2010). High-throughput prediction of protein antigenicity using protein microarray data. Bioinformatics, 26, 2936–2943.
  • Maisonneuve, C., Bertholet, S., Philpott, D. J., & De Gregorio, E. (2014). Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants. Proceedings of the National Academy of Sciences of the United States of America, 111, 12294–12299.
  • Mashiach, E., Schneidman-Duhovny, D., Andrusier, N., Nussinov, R., & Wolfson, H. J. (2008). FireDock: A web server for fast interaction refinement in molecular docking. Nucleic Acids Research, 36, W229–W232. doi:10.1093/nar/gkn186
  • Mathew, A., Kurane, I., Green, S., Stephens, H. A. F., Vaughn, D. W., Kalayanarooj, S., … Rothman, A. L. (1998). Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection. Journal of Virology, 72, 3999–4004. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC109627/
  • Murray, N. E. A., Quam, M. B., & Wilder-Smith, A. (2013). Epidemiology of dengue: Past, present and future prospects. Clinical Epidemiology, 5, 299–309.
  • Muthusamy, K., Gopinath, K., & Nandhini, D. (2016). Computational prediction of immunodominant antigenic regions & potential protective epitopes for dengue vaccination. Indian Journal of Medical Microbiology, 144, 587.
  • Muzio, M., Polentarutti, N., Bosisio, D., Prahladan, M. K. P., & Mantovani, A. (2000). Toll‐like receptors: A growing family of immune receptors that are differentially expressed and regulated by different leukocytes. Journal of Leukocyte Biology, 67, 450–456.
  • Naz, A., Awan, F. M., Obaid, A., Muhammad, S. A., Paracha, R. Z., Ahmad, J., & Ali, A. (2015). Identification of putative vaccine candidates against Helicobacter pylori exploiting exoproteome and secretome: A reverse vaccinology based approach. Infection, Genetics and Evolution, 32, 280–291.
  • Negahdaripour, M., Eslami, M., Nezafat, N., Hajighahramani, N., Ghoshoon, M. B., Shoolian, E., … Ghasemi, Y. (2017). A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approaches. Infection, Genetics and Evolution, 54, 402–416.
  • Negahdaripour, M., Golkar, N., Hajighahramani, N., Kianpour, S., Nezafat, N., & Ghasemi, Y. (2017). Harnessing self-assembled peptide nanoparticles in epitope vaccine design. Biotechnology Advances, 35, 75–596.
  • Nezafat, N., Eslami, M., Negahdaripour, M., Rahbar, M. R., & Ghasemi, Y. (2017). Designing an efficient multi-epitope oral vaccine against Helicobacter pylori using immunoinformatics and structural vaccinology approaches. Molecular BioSystems, 13, 699–713.
  • Nezafat, N., Ghasemi, Y., Javadi, G., Khoshnoud, M. J., & Omidinia, E. (2014). A novel multi-epitope peptide vaccine against cancer: An in silico approach. Journal of Theoretical Biology, 349, 121–134.
  • Nezafat, N., Karimi, Z., Eslami, M., Mohkam, M., Zandian, S., & Ghasemi, Y. (2016). Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches. Computational Biology and Chemistry, 62, 82–95.
  • Nezafat, N., Sadraeian, M., Rahbar, M. R., Khoshnoud, M. J., Mohkam, M., Gholami, A., … Ghasemi, Y. (2015). Production of a novel multi-epitope peptide vaccine for cancer immunotherapy in TC-1 tumor-bearing mice. Biologicals, 43(1), 11–17. doi:10.1016/j.biologicals.2014.11.001
  • Oyarzún, P., & Kobe, B. (2016). Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production. Human Vaccines and Immunotherapeutics, 12, 763–767. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964635/
  • Parra-López, C., Calvo-Calle, J. M., Cameron, T. O., Vargas, L. E., Salazar, L. M., Patarroyo, M. E., … Stern, L. J. (2006). Major histocompatibility complex and T cell interactions of a universal T cell epitope from Plasmodium falciparum circumsporozoite protein. Journal of Biological Chemistry, 281, 14907–14917.
  • Pasare, C., & Medzhitov, R. (2004). Toll-like receptors and acquired immunity. Seminars in Immunology, 16(1), 23–26.
  • Rosendahl Huber, S., van Beek, J., de Jonge, J., Luytjes, W., & van Baarle, D. (2014). T cell responses to viral infections—Opportunities for peptide vaccination. Frontiers in Immunology, 5, 171. doi:10.3389/fimmu.2014.00171 Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997009/
  • Saha, C. K., Hasan, M. M., Hossain, M. S., Jahan, M. A., & Azad, A. K. (2017). In silico identification and characterization of common epitope-based peptide vaccine for Nipah and Hendra viruses. Asian Pacific Journal of Tropical Medicine, 10, 529–538.
  • Saha, S., & Raghava, G. (2006). AlgPred: Prediction of allergenic proteins and mapping of IgE epitopes. Nucleic Acids Research, 34, W202–W209.
  • Sakib, M. S., Islam, M. R., Hasan, A. K., & Nabi, A. H. (2014). Prediction of epitope-based peptides for the utility of vaccine development from fusion and glycoprotein of nipah virus using in silico approach. Adv Bioinformatics, 2014, 402492. doi:10.1155/2014/402492
  • Sette, A., Livingston, B., McKinney, D., Appella, E., Fikes, J., Sidney, J., … Chesnut, R. (2001). The development of multi-epitope vaccines: Epitope identification, vaccine design and clinical evaluation. Biologicals, 29, 271–276.
  • Somvanshi, P, & Seth, P. (2009). Prediction of T cell epitopes for the utility of vaccine development from structural proteins of dengue virus variants using in silico methods. Indian Journal of Biotechnology. 8, 193–198.
  • Soria-Guerra, R. E., Nieto-Gomez, R., Govea-Alonso, D. O., & Rosales-Mendoza, S. (2015). An overview of bioinformatics tools for epitope prediction: Implications on vaccine development. Journal of Biomedical Informatics, 53, 405–414. Retrieved from http://www.sciencedirect.com/science/article/pii/S1532046414002330
  • Stern, L. J., & Calvo-Calle, J. M. (2009). HLA-DR: Molecular insights and vaccine design. Current Pharmaceutical Design, 15, 3249–3261. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615543/
  • Torchala, M., Moal, I. H., Chaleil, R. A., Fernandez-Recio, J., & Bates, P. A. (2013). SwarmDock: A server for flexible protein–protein docking. Bioinformatics, 29, 807–809.
  • Toussi, D. N., & Massari, P. (2014). Immune adjuvant effect of molecularly-defined toll-like receptor ligands. Vaccines, 2, 323–353.
  • Tuiskunen Bäck, A., & Lundkvist, Å. (2013). Dengue viruses–An overview. Infection Ecology and Epidemiology, 3(1), 19839.
  • Vita, R., Overton, J. A., Greenbaum, J. A., Ponomarenko, J., Clark, J. D., Cantrell, J. R., … Sette, A. (2014). The immune epitope database (IEDB) 3.0. Nucleic Acids Research, 43, D405–D412.
  • Wang, Y, Virtanen, J, Xue, Z, & Zhang, Y. (2017). I-TASSER-MR: automated molecular replacement for distant-homology proteins using iterative fragment assembly and progressive sequence truncation. Nucleic acids research, 45, W429–W34.
  • Weiskopf, D., & Sette, A. (2014). T-cell immunity to infection with dengue virus in humans. Frontiers in Immunology, 5, 93.
  • Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35, W407–W410.
  • Yamashita, Y., Anczurowski, M., Nakatsugawa, M., Tanaka, M., Kagoya, Y., Sinha, A., … Hirano, N. (2017). HLA-DP(84Gly) constitutively presents endogenous peptides generated by the class I antigen processing pathway. Nature Communications, 8, 15244. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436232/
  • Yang, Y., Sun, W., Guo, J., Zhao, G., Sun, S., Yu, H., … Du, L. (2015). In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations. Human Vaccines and Immunotherapeutics, 11, 795–805.
  • Yano, A., Onozuka, A., Asahi-Ozaki, Y., Imai, S., Hanada, N., Miwa, Y., & Nisizawa, T. (2005). An ingenious design for peptide vaccines. Vaccine, 23, 2322–2326.
  • Zarei, M., Nezafat, N., Rahbar, M. R., Negahdaripour, M., Sabetian, S., Morowvat, M. H., & Ghasemi, Y. (2018). Decreasing the immunogenicity of arginine deiminase enzyme via structure-based computational analysis. Journal of Biomolecular Structure and Dynamics, doi: 10.1080/07391102.2018.1431151
  • Zheng, J., Lin, X., Wang, X., Zheng, L., Lan, S., Jin, S., … Wu, J. (2017). In silico analysis of epitope-based vaccine candidates against hepatitis B virus polymerase protein. Viruses, 9, 112.
  • Zuo, J., Hislop, A. D., Leung, C. S., Sabbah, S., & Rowe, M. (2013). Kaposi’s sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and-independent mechanisms: Implications for oncogenesis. Journal of Virology, 87, 5340–5350.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.